2. Sleep Apnea by Numbers
• Obstructive Sleep Apnea (OSA) affects 18
million Americans
• OSA increases risks for
–Hypertension by 2.9 times
–Stroke by 3.8 times, and
–Car crashes by 2.4 times
7. CPAP… and Adherence
• CPAP is an effective first-line therapy for OSA patients
who use it consistently
• General CPAP adherence is about 50%
• Many factors limit adherence
7
11. Development Process
Plan
• Needs
• Features
• Requirements
Development
• Design
• Prototype
• Manufacture
Testing
• Bench test
• Pre-clinical
testing
• Human
testing
12. Clinical Testing
8 patients @ 4
centers
2001
First in man
1 publication
Inspire 2&3
Feasibility Trials
22 patients @ 4
centers
2009/10
Patient selection
Implant technique
1 peer reviewed
publication
126 patients @ 22
centers
2012 /13
Safety / Efficacy /
FDA Review
N Eng J Med &
other publications
Inspire STAR
Pivotal Trial
12 patients @ 7
centers
2010/11
Preliminary
Safety / Efficacy
2 peer reviewed
publications
Inspire 2/3
Feasibility Study
Inspire 1
Proof of Principle
Inspire 2/3
Feasibility Study
FDA Approval April 2014
14. Significant Reduction In OSA Severity
Strollo et al on behalf of STAR trial investigators N Engl J Med 2014
15. Strollo et al on behalf of STAR trial investigators N Engl J Med 2014
16. Improve Daytime Functioning
Epworth Sleepiness Scale (synthesized): chance of dozing (0-3) during 8 situations:
Sitting and reading; Watch TV; Meeting; Passenger in a car;
Lying down in PM; Sitting and talking; Sitting after lunch; Sitting in traffic
17. Partner-Reported Level of Snoring
17
6.5%
49.0%
11.1%
36.0%
28.7%
7.0%
24.1%
3.0%
29.6%
5.0%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
Baseline 12-Months
PercentofPartners
Bed partner leaves room
Very intense snoring annoying to
anyone nearby
Loud snoring, enough to be
bothersome to the bed partner
Soft snoring which doesn’t
interrupt the bed partner’s sleep
(social snoring)
No snoring at all
n=108 n=100
18%
85%
STAR trial data